<DOC>
	<DOCNO>NCT02205307</DOCNO>
	<brief_summary>This randomize , control , parallel , multicenter study determine difference post-operative anastomotic leak rate low anterior resection procedure colon rectal tissue perfusion evaluate use PINPOINT adjunct standard surgical practice compare surgical procedure perform accord standard surgical practice alone .</brief_summary>
	<brief_title>A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging Low Anterior Resection</brief_title>
	<detailed_description />
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Be 18 year age old . Be undergoing open , minimally invasive LAR treatment rectal rectosigmoid neoplasm ( Subjects rectal rectosigmoid neoplasm ( ) may treat without neoadjuvant therapy . Longcourse neoadjuvant therapy must complete ≥6 week prior LAR surgery ( Day 0 ) . Have plan low circular staple transanally hand sewn anastomosis ≤10 cm anal verge . Have colorectal coloanal reconstruction without reservoir/pouch . Subjects woman childbearing potential must pregnant lactating , must negative pregnancy test Day 0 . Have sign approve informed consent form study . Be willing comply protocol . Undergoing stapled anastomosis use experimental nonFDA approve stapler . Undergoing ileoanal reconstruction , total colectomy proctocolectomy , abdominoperineal resection , Hartmann 's procedure , Hartmann 's reversal multiple synchronous colon resection ( e.g. , LAR concomitant right colectomy ) . Has receive complete course pelvic radiotherapy ≥ 6 month prior LAR surgery ( Day 0 ) . Has previously undergone leave sided colon resection . Has previously undergone rectal resection . Has recurrent rectal rectosigmoid cancer . Has diagnosis locally advance rectal rectosigmoid cancer undergo extend en bloc operation . Has diagnosis Stage IV rectal rectosigmoid cancer multifocal metastasis single site metastasis tumor size &gt; 2 cm ( Intraoperative incidental find preoperative suspicion Stage IV cancer isolate ( single site ) metastasis ( ≤ 2 cm ) limit metastasis ( ≤3 ) , large lesion ≤ 2 cm size , exclude subject ) . Has diagnosis inflammatory bowel disease ( IBD ) . Subjects rectal rectosigmoid cancer neoplasm IBD exclude . Has hepatic dysfunction define Model EndStage Liver Disease ( MELD ) Score &gt; 12 . Renal dysfunction define creatinine ≥ 2.0 mg/dL . Has know allergy history adverse reaction ICG , iodine iodine dye . Has , Investigator 's opinion , medical condition make subject poor candidate investigational procedure , interfere interpretation study result . Is actively participate another investigational clinical study , Investigator 's Sponsor 's opinion , would interfere study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>Rectal neoplasm</keyword>
	<keyword>Colorectal surgery</keyword>
	<keyword>Anastomosis</keyword>
</DOC>